Heparin and osteoporosis during pregnancy: 2002 update

@article{RuizIrastorza2002HeparinAO,
  title={Heparin and osteoporosis during pregnancy: 2002 update},
  author={G. Ruiz-Irastorza and M. Khamashta and G. Hughes},
  journal={Lupus},
  year={2002},
  volume={11},
  pages={680 - 682}
}
  • G. Ruiz-Irastorza, M. Khamashta, G. Hughes
  • Published 2002
  • Medicine
  • Lupus
  • Althoughsignificant bone mass loss is rare duringpregnancy,some situationsmay increasethe risk of symptomaticosteoporosis.Heparin may be necessaryfor a number of pregnantwomen with systemic lupus erythematosus and antiphospholipid syndrome. The osteopenic effect of heparin is low even during pregnancy, and recent data point to a more favourable profile of low-molecular-weight heparins as compared with unfractionated heparin. Lactation results in a significant increase of calcium demands and may… CONTINUE READING
    23 Citations
    Antiphospholipid syndrome: Diagnosis and management in the obstetric patient.
    • 3
    Antiphospholipid syndrome: treatment controversies
    • 3
    Anti-inflammatory and immunosuppressive drugs and reproduction
    • 473
    • PDF

    References

    SHOWING 1-10 OF 19 REFERENCES
    Safety of low-molecular-weight heparin in pregnancy: a systematic review.
    • 524
    Pregnancy-associated osteoporosis
    • 21
    Bone density studies in pregnant women receiving heparin.
    • 114
    Long-term use of oral anticoagulants and the risk of fracture.
    • 155
    • PDF
    Warfarin Use and Risk for Osteoporosis in Elderly Women
    • 147